Literature DB >> 23083337

Does anti-hepatitis B virus vaccine make any difference in long-term number of liver transplantation?

E Chaib1, B G M M Coimbra, F H F Galvão, E R Tatebe, M S Shinzato, L A C D'Albuquerque, E Massad.   

Abstract

BACKGROUND: Hepatitis B virus (HBV) infection is a major cause of morbidity and mortality worldwide. Chronic hepatitis B infection is associated with an increased risk of cirrhosis, hepatic decompensation, and hepatocellular carcinoma. Our aim is to analyze, through a mathematical model, the potential impact of anti-HBV vaccine in the long-term (that is, decades after vaccination) number of LT.
METHODS: The model simulated that the prevalence of HBV infection was 0.5% and that approximately 20% of all the liver transplantation carried out in the state of São Paulo are due to HBV infection.
RESULTS: The theoretical model suggests that a vaccination program that would cover 80% of the target population would reach a maximum of about 14% reduction in the LT program.
CONCLUSION: Increasing the vaccination coverage against HBV in the state of São Paulo would have a relatively low impact on the number of liver transplantation. In addition, this impact would take several decades to materialize due to the long incubation period of liver failure due to HBV.
© 2012 John Wiley & Sons A/S.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23083337     DOI: 10.1111/ctr.12030

Source DB:  PubMed          Journal:  Clin Transplant        ISSN: 0902-0063            Impact factor:   2.863


  3 in total

Review 1.  Review of the pharmacological management of hepatitis B viral infection before and after liver transplantation.

Authors:  Evangelos Cholongitas; George V Papatheodoridis
Journal:  World J Gastroenterol       Date:  2013-12-28       Impact factor: 5.742

Review 2.  Management of patients with hepatitis B in special populations.

Authors:  Evangelos Cholongitas; Konstantinos Tziomalos; Chrysoula Pipili
Journal:  World J Gastroenterol       Date:  2015-02-14       Impact factor: 5.742

3.  A mathematical model for optimizing the indications of liver transplantation in patients with hepatocellular carcinoma.

Authors:  Eleazar Chaib; Marcos Amaku; Francisco A B Coutinho; Luis F Lopez; Marcelo N Burattini; Luiz Ac D'Albuquerque; Eduardo Massad
Journal:  Theor Biol Med Model       Date:  2013-10-20       Impact factor: 2.432

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.